Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...

Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as new therapies expand global market leadership.

Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market ...

BlackRock Health Sciences Trust is a Buy for income investors, offering an 8% yield, NAV discount, and resilient healthcare ...

BofA analyst Jason Gerberry lowered the firm’s price target on Eli Lilly (LLY) to $1,268 from $1,286 and keeps a Buy rating ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the ...

Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbre ...

FDA may slap COVID-19 vaccines with “black box” warning; FDA to speed up process of Lilly’s oral pill; GSK CEO says the U.S. is the best country to invest in.

Indiana officials on Thursday announced a nearly $75 million public–private investment aimed at strengthening literacy, STEM ...

Before Saturday’s snowstorm passed through the area, Seymour’s swim teams had already logged a productive day. Besides getting in pre- and post-meet workouts, the Owls dominated the six-team “S” Super ...